Vitiligo News and Research

RSS
Vitiligo is a pigmentation disorder in which melanocytes (the cells that make pigment) in the skin are destroyed. As a result, white patches appear on the skin in different parts of the body. Similar patches also appear on both the mucous membranes (tissues that line the inside of the mouth and nose) and the retina (inner layer of the eyeball). The hair that grows on areas affected by vitiligo sometimes turns white.

The cause of vitiligo is not known, but doctors and researchers have several different theories. There is strong evidence that people with vitiligo inherit a group of three genes that make them susceptible to depigmentation. The most widely accepted view is that the depigmentation occurs because vitiligo is an autoimmune disease – a disease in which a person's immune system reacts against the body's own organs or tissues. People's bodies produce proteins called cytokines that, in vitiligo, alter their pigment-producing cells and cause these cells to die. Another theory is that melanocytes destroy themselves. Finally, some people have reported that a single event, such as sunburn or emotional distress, triggered vitiligo; however, these events have not been scientifically proven as causes of vitiligo.
Genes that control the immune system may play role in hair graying

Genes that control the immune system may play role in hair graying

Dermatologists use novel combination therapy to restore skin color in vitiligo patients

Dermatologists use novel combination therapy to restore skin color in vitiligo patients

Genes that determine skin color studied - new revelations

Genes that determine skin color studied - new revelations

Skin transplant surgery has long-term benefit for restoring pigmentation caused by vitiligo

Skin transplant surgery has long-term benefit for restoring pigmentation caused by vitiligo

Cancer treatment may be effective therapy for psoriasis

Cancer treatment may be effective therapy for psoriasis

Researchers show resident T cells in the skin depend on CD103 molecule for their anti-tumor function

Researchers show resident T cells in the skin depend on CD103 molecule for their anti-tumor function

New treatment option could provide effective therapy for patients with dermatologic conditions

New treatment option could provide effective therapy for patients with dermatologic conditions

Study opens way for targeted local treatments for patchy skin disorders

Study opens way for targeted local treatments for patchy skin disorders

Contact dermatitis or contact eczema?

Contact dermatitis or contact eczema?

JAK inhibitors show promise in restoring hair growth in patients with alopecia areata

JAK inhibitors show promise in restoring hair growth in patients with alopecia areata

JAK inhibitors may be first effective treatment for people with alopecia areata

JAK inhibitors may be first effective treatment for people with alopecia areata

Study provides new insights into development of skin-depigmenting disease vitiligo

Study provides new insights into development of skin-depigmenting disease vitiligo

New research on EdnrB, Wnt signaling pathways could lead to therapies for skin pigment disorders

New research on EdnrB, Wnt signaling pathways could lead to therapies for skin pigment disorders

Researchers successfully treat eczema patients using rheumatoid arthritis drug

Researchers successfully treat eczema patients using rheumatoid arthritis drug

UT Southwestern dermatologist improves technique to treat skin discoloration from vitiligo

UT Southwestern dermatologist improves technique to treat skin discoloration from vitiligo

Avita Medical’s ReCell technology safe, effective for patients suffering with depigmented skin lesions

Avita Medical’s ReCell technology safe, effective for patients suffering with depigmented skin lesions

Penn study has implications for developing new cell-based treatments for skin disease

Penn study has implications for developing new cell-based treatments for skin disease

PhotoMedex revenues decrease 12% to $50.1 million in first quarter 2014

PhotoMedex revenues decrease 12% to $50.1 million in first quarter 2014

PhotoMedex Q4 2013 revenues up 16% to $63.5 million

PhotoMedex Q4 2013 revenues up 16% to $63.5 million

PhotoMedex terminates exclusive distribution agreement between Radiancy and Ya-Man in Japan

PhotoMedex terminates exclusive distribution agreement between Radiancy and Ya-Man in Japan